Next generation therapeutics for Alzheimer's disease
Abstract To date, no truly effective therapy has been developed for Alzheimer's disease or mild cognitive impairment. In searching for new approaches that may succeed where previous ones have failed, it may be instructive to consider the successful therapeutic developments for other chronic ill...
Κύριοι συγγραφείς: | Dale E. Bredesen, Varghese John |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Springer Nature
2013-05-01
|
Σειρά: | EMBO Molecular Medicine |
Θέματα: | |
Διαθέσιμο Online: | https://doi.org/10.1002/emmm.201202307 |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Potential Antioxidant Multitherapy against Complications Occurring in Sepsis
ανά: Joaquin Abelli, κ.ά.
Έκδοση: (2022-12-01) -
Emerging advances in fluorescence imaging and phototherapy of arthritis
ανά: Xiaoxuan Wang, κ.ά.
Έκδοση: (2023-11-01) -
Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives
ανά: María Gabriela Montiel Schneider, κ.ά.
Έκδοση: (2022-01-01) -
Editorial: Highlights in Alzheimer's and Parkinson's disease
ανά: Mariagiovanna Cantone, κ.ά.
Έκδοση: (2023-08-01) -
Insights from Turkey's big data: unraveling the preventability, pathogenesis, and risk management of Alzheimer's disease (AD)
ανά: Talip Yiğit, κ.ά.
Έκδοση: (2024-03-01)